These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effectiveness of treatment with mezlocillin, ampicillin and latamoxef (moxalactam) of experimental group B beta-haemolytic streptococcal meningitis in rabbits.
    Author: Khurana CM, Deddish PA.
    Journal: J Antimicrob Chemother; 1983 Feb; 11(2):125-33. PubMed ID: 6219981.
    Abstract:
    This study compared the effectiveness of treatment with various antibiotics in rabbits with experimental group B beta-haemolytic streptococcal meningitis. Groups of nine infected rabbits each received the following treatments intramuscularly, three times per day: (1) control--no treatment; (2) mezlocillin--400 mg/kg/day; (3) mezlocillin--400 mg/kg/day + gentamicin--15 mg/kg/day; (4) ampicillin--400 mg/kg/day; (5) ampicillin--400 mg/kg/day + gentamicin 15 mg/kg/day; (6) latamoxef (moxalactam)--100 mg/kg/day. Bacterial counts in the cerebrospinal fluid (CSF) and drug levels in the serum and CSF were measured each hour for 7 h and at 24, 48 and 72 h after start of therapy. Percent penetration values (CSF concentration/serum concentration X 100) for the drugs were calculated and effectiveness of bacterial clearing from the CSF was determined. Over the 72 h period, the most effective therapy was mezlocillin + gentamicin, followed by ampicillin + gentamicin, mezlocillin, ampicillin and latamoxef in order of effectiveness in clearing bacteria from the CSF.
    [Abstract] [Full Text] [Related] [New Search]